MOG antibody disease is an autoimmune disease of the central nervous system associated
with a serological antibody against MOG, myelin oligodendrocyte glycoprotein. MOG is a …

Background Since the declaration of COVID-19 pandemic, several case reports of demyelination
of both peripheral and central nervous systems have been published. The association …

We describe the landscape of somatic genomic alterations based on multidimensional and
comprehensive characterization of more than 500 glioblastoma tumors (GBMs). We identify …

Therapy development for adult diffuse glioma is hindered by incomplete knowledge of somatic
glioma driving alterations and suboptimal disease classification. We defined the complete …

The developmental and evolutionary mechanisms behind the emergence of human-specific
brain features remain largely unknown. However, the recent ability to compare our genome …

Background Since the emergency use approval of different types of COVID-19 vaccines,
several safety concerns have been raised regarding its early and delayed impact on the …

… To determine whether rapamycin reduces cell size during other phases of the cell cycle, we
examined the mean FSC-H of S-phase and G 2 /M-phase cells. Rapamycin decreased cell …

Existing human genome assemblies have almost entirely excluded repetitive sequences
within and near centromeres, limiting our understanding of their organization, evolution, and …

Many approaches to identify therapeutically relevant neoantigens couple tumor sequencing
with bioinformatic algorithms and inferred rules of tumor epitope immunogenicity. However, …

… Finally, we used QUAST to calculate disagreements between the T2T Consortium’s
chromosome X assembly, a highly curated, validated assembly 32 and the subset of each CHM13 …